MediciNova, Inc. (MNOV)
1.35
-0.14
(-9.40%)
USD |
NASDAQ |
Feb 24, 16:00
1.36
+0.01
(+0.74%)
Pre-Market: 20:00
MediciNova Research and Development Expense (Quarterly) : 1.543M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Biogen, Inc. | 434.00M |
| Cytokinetics, Inc. | 96.55M |
| Ionis Pharmaceuticals, Inc. | 217.13M |
| Aldeyra Therapeutics, Inc. | 5.431M |
| Amylyx Pharmaceuticals, Inc. | 19.74M |